Baseline characteristics

177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer · Source last updated 2026-08-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      234

   2. group Id

      BG001

      value

      234

   3. group Id

      BG002

      value

      468

   units

   Participants

groups

1. description

   Participants received 7.4 GBq (200 mCi) +/- 10% 177Lu-PSMA-617 once every 6 weeks for 6 cycles. Best supportive care, including ADT could be used.

   id

   BG000

   title

   177Lu-PSMA-617 (AAA617)

2. description

   For participants randomized to the ARDT arm, the change of ARDT treatment was administered per the physician's orders. Best supportive care, including ADT could be used.

   id

   BG001

   title

   Androgen Receptor-directed Therapy (ARDT)

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            8.70

            value

            71.0

         2. group Id

            BG001

            spread

            7.65

            value

            71.9

         3. group Id

            BG002

            spread

            8.19

            value

            71.4

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            0

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            234

         2. group Id

            BG001

            value

            234

         3. group Id

            BG002

            value

            468

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            1

         2. group Id

            BG001

            value

            2

         3. group Id

            BG002

            value

            3

      title

      Asian

   2. categories

      1. measurements

         1. group Id

            BG000

            value

            7

         2. group Id

            BG001

            value

            5

         3. group Id

            BG002

            value

            12

      title

      Black or African American

   3. categories

      1. measurements

         1. group Id

            BG000

            value

            212

         2. group Id

            BG001

            value

            214

         3. group Id

            BG002

            value

            426

      title

      White

   4. categories

      1. measurements

         1. group Id

            BG000

            value

            14

         2. group Id

            BG001

            value

            13

         3. group Id

            BG002

            value

            27

      title

      Unknown

   param Type

   NUMBER

   title

   Race/Ethnicity, Customized

   unit Of Measure

   Participants

population Description

The Full Analysis Set (FAS) comprised all participants to whom study treatment was assigned by randomization.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice